Untitled

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.

[syridexbio]

Investing in Therapies that Accelerate Health Equity

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow. At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting minoritized communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.

[syridexbio]

Syridex Bio - About us

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. Syridex Bio was founded on the belief that everyone deserves the opportunity to live a healthy life. For too long, deep inequities have persisted across our pharmaceutical, biotechnology, and medical systems. Despite increased public attention on the problem in recent years, progress remains far too slow. At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting minoritized communities. By financing the development of drugs and treatments addressing the world’s greatest health disparities, we are convinced that we can accelerate health equity globally and achieve strong financial returns for our investors.

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affe

[syridexbio]

5 posts!

[syridexbio]

Triple-negative breast cancer highlights the need Syridex Bio

Did you know that breast cancer disproportionally affects women of color in the United States? Specifically, Triple Negative Breast Cancer (TNBC) is of concern for Black and Hispanic populations. These groups are more likely to be diagnosed with this aggressive cancer, and to have a higher mortality rate, compared to non-Hispanic white women. At Syridex Bio, our mission is to identify health inequities, such as those surrounding TNBC, and to invest in therapies that help close the gap among these underserved communities. Learn more about health inequities related to TNBC here: https://lnkd.in/ed4cTr-g & https://www.syridexbio.com/

#healthcare #health_inequity #HealthEquality #unitedstates #cancer #syridexbio #tnbc #health_inequity

[syridexbio]

Triple-negative breast cancer highlights the need Syridex Bio

Did you know that breast cancer disproportionally affects women of color in the United States? Specifically, Triple Negative Breast Cancer (TNBC) is of concern for Black and Hispanic populations. These groups are more likely to be diagnosed with this aggressive cancer, and to have a higher mortality rate, compared to non-Hispanic white women. At Syridex Bio, our mission is to identify health…

View On WordPress

[syridexbio]

Syridex Bio is an impact-driven

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. We are filling this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting minoritized communities. Learn more about Syridex Bio and our mission here: https://lnkd.in/e2fzpiCM & https://www.syridexbio.com/

[syridexbio]

Syridex Bio is an impact-driven

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities.

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that accelerate global health equity by addressing the needs of underserved communities. We are filling this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting minoritized communities. Learn more about Syridex Bio and our mission here: https://lnkd.in/e2fzpiCM…

View On WordPress

[syridexbio]

Advancing health equity Syridex Bio

At Syridex Bio, we are addressing this gap in the market by strategically investing in therapies that treat diseases disproportionately affecting underserved communities.

Advancing health equity’ is a trendy concept in the healthcare industry right now, and many organizations trying to move the needle on change in this space have been turning to increased data collection and analysis as the first step forward. However, healthcare systems and organizations are already armed with enough data to begin making impactful change, as Forbes notes in a recent…

View On WordPress

[syridexbio]

Advancing health equity Syridexbio

Advancing health equity’ is a trendy concept in the healthcare industry right now, and many organizations trying to move the needle on change in this space have been turning to increased data collection and analysis as the first step forward. However, healthcare systems and organizations are already armed with enough data to begin making impactful change, as Forbes notes in a recent article.   At Syridex Bio, we are actively working to address health inequities by investing in therapies to treat diseases that disproportionately affect minority populations, effectively filling a gap in the healthcare market to provide access and treatment options for historically underserved communities. Read the Forbes article to learn how taking actionable steps now can advance progress toward health equity: https://lnkd.in/ex_puw6W & https://www.syridexbio.com/

[syridexbio]

Everyone deserves the opportunity to live a healthy life

Everyone deserves the opportunity to live a healthy life. However, according to this recent World Economic Forum article, up to 70% of health outcome disparities are due to non-medical drivers of health – including factors like financial security, housing, and other social, economic, and environmental pressures. With this frame of reference, every company can contribute to advancing health equity by providing the benefits necessary for a healthy life, ensuring its offerings lead to equitable outcomes, and investing in community initiatives.

Recognizing this relationship between medical and non-medical factors affecting health, the CVS Health Foundation, for example, has invested $185 million in affordable housing in underserved communities to support health equity, while the Novo Nordisk Group has worked with more than 40 cities worldwide to address the systemic issues underlying obesity and type 2 diabetes. Read the full article to learn how every company can accelerate corporate action towards addressing health inequities: https://lnkd.in/eAtpPQa8.  & https://www.syridexbio.com/

#healthequity#equity#impactinvesting#syridexbio

[syridexbio]

Everyone deserves the opportunity to live a healthy life

Everyone deserves the opportunity to live a healthy life. However, according to this recent World Economic Forum article, up to 70% of health outcome disparities are due to non-medical drivers of health – including factors like financial security, housing, and other social, economic, and environmental pressures. With this frame of reference, every company can contribute to advancing health equity…

View On WordPress

[syridexbio]

Investing in Therapies that Accelerate Health Equity

In the healthcare sector, the invisible hand of the market has historically helped to hold health inequities in place. Without an intentional investor focus on equity, the market has channelled capital mostly toward health advancements perceived to have the broadest market size and greatest potential for return. However, that same market power can be harnessed to drive real progress for underserved communities.   Guided by impact-minded investors, the invisible hand of the market offers the most promising opportunity for broad and lasting change. Investment in therapies that intentionally serve the underserved lays the foundation for true social justice in healthcare and opens the door to a brighter, healthier global future. Learn more about the necessary role of impact investors in achieving social justice in healthcare in Syridex Bio’s latest article: https://lnkd.in/e68J5xbU & https://www.syridexbio.com/